EP0705108A4 - Verwendung von kryptischen peptiden zur induktion immunologisches toleranz - Google Patents

Verwendung von kryptischen peptiden zur induktion immunologisches toleranz

Info

Publication number
EP0705108A4
EP0705108A4 EP94916845A EP94916845A EP0705108A4 EP 0705108 A4 EP0705108 A4 EP 0705108A4 EP 94916845 A EP94916845 A EP 94916845A EP 94916845 A EP94916845 A EP 94916845A EP 0705108 A4 EP0705108 A4 EP 0705108A4
Authority
EP
European Patent Office
Prior art keywords
peptides
hidden
immunological tolerance
inducing immunological
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94916845A
Other languages
English (en)
French (fr)
Other versions
EP0705108A1 (de
Inventor
Wayne Robert Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telethon Kids Institute TVW
Original Assignee
Telethon Kids Institute TVW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telethon Kids Institute TVW filed Critical Telethon Kids Institute TVW
Publication of EP0705108A1 publication Critical patent/EP0705108A1/de
Publication of EP0705108A4 publication Critical patent/EP0705108A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP94916845A 1993-06-02 1994-06-01 Verwendung von kryptischen peptiden zur induktion immunologisches toleranz Withdrawn EP0705108A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72832 1987-07-13
US7283293A 1993-06-02 1993-06-02
PCT/AU1994/000292 WO1994027634A1 (en) 1993-06-02 1994-06-01 Cryptic peptides for use in inducing immunologic tolerance

Publications (2)

Publication Number Publication Date
EP0705108A1 EP0705108A1 (de) 1996-04-10
EP0705108A4 true EP0705108A4 (de) 1997-08-06

Family

ID=22110024

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94916845A Withdrawn EP0705108A4 (de) 1993-06-02 1994-06-01 Verwendung von kryptischen peptiden zur induktion immunologisches toleranz

Country Status (6)

Country Link
EP (1) EP0705108A4 (de)
JP (1) JPH09509135A (de)
AU (1) AU674584B2 (de)
CA (1) CA2164326A1 (de)
NZ (1) NZ266739A (de)
WO (1) WO1994027634A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0783322A1 (de) * 1994-09-02 1997-07-16 Immunologic Pharmaceutical Corporation Peptidzusammensetzungen mit der fähigkeitantigenspezifische immunantworten herunterregulieren zu können
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
CA2232834A1 (en) * 1995-09-21 1997-03-27 University Of Utah Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
JPH09194393A (ja) 1996-01-22 1997-07-29 Meiji Milk Prod Co Ltd 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット
US6737406B1 (en) 1996-03-21 2004-05-18 Circassia, Ltd. Cryptic peptides and method for their identification
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6024961A (en) * 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
US7128921B1 (en) 1998-04-17 2006-10-31 Heska Corporation Dermatophagoides proteins and fragments thereof
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
CA2554337A1 (en) 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
NZ583362A (en) 2007-08-15 2012-06-29 Circassia Ltd Peptide with reduced dimer formation
CN110064049B (zh) 2012-06-21 2024-02-09 西北大学 肽缀合粒子
KR20160042079A (ko) 2013-08-13 2016-04-18 노쓰웨스턴유니버시티 펩티드-접합된 입자
JP7194593B2 (ja) 2015-12-23 2022-12-22 クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド 共有ポリマー抗原コンジュゲート化粒子
WO2025199149A1 (en) 2024-03-18 2025-09-25 Cour Pharmaceuticals Development Company Inc. Sting agonism for antigen specific tolerance

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008279A1 (en) * 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2993967B2 (ja) * 1987-06-17 1999-12-27 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダニアレルゲンのクローニング
EP0359783B2 (de) * 1987-06-24 2002-04-17 Autoimmune, Inc. Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
CA2070281C (en) * 1989-12-20 2005-08-23 David Allen Hafler Improved treatment of autoimmune diseases by aerosol administration of auto antigens
AU651097B2 (en) * 1990-03-02 1994-07-14 Autoimmune, Inc. Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
EP0503055A1 (de) * 1990-09-06 1992-09-16 Rijksuniversiteit Utrecht Inhibitor der lymphozyten-antwort und immunverwandter krankheiten
WO1992004632A1 (en) * 1990-09-07 1992-03-19 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
HUT69942A (en) * 1990-10-15 1995-09-28 Brigham & Womens Hospital Treatment of autoimmun diseases by oral administration of autoantigenes
HU220357B (hu) * 1992-02-28 2001-12-28 Autoimmune Inc. Eljárás és készítmények autoimmun betegségek kezelésére bystander antigén alkalmazásával
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008279A1 (en) * 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
H.YSSEL ET AL.: "T cell activation-inducing epitopes of the house dust mite allergen Der pI", JOURNAL OF IMMUNOLOGY, vol. 148, no. 3, 1 February 1992 (1992-02-01), BALTIMORE US, pages 738 - 745, XP002025554 *
P.JEANNIN ET AL.: "Specific histamine release capacity of peptides selected from the modelized De P I protein, a major allergen of Dermatophagoides pteronyssinus", MOLECULAR IMMUNOLOGY, vol. 29, no. 6, June 1992 (1992-06-01), pages 739 - 749, XP002025555 *
See also references of WO9427634A1 *

Also Published As

Publication number Publication date
EP0705108A1 (de) 1996-04-10
CA2164326A1 (en) 1994-12-08
WO1994027634A1 (en) 1994-12-08
NZ266739A (en) 1997-07-27
AU674584B2 (en) 1997-01-02
JPH09509135A (ja) 1997-09-16
AU6838594A (en) 1994-12-20

Similar Documents

Publication Publication Date Title
EP0705108A4 (de) Verwendung von kryptischen peptiden zur induktion immunologisches toleranz
DE69416964D1 (de) Beleuchtungsanlage
DK0739831T3 (da) Transportør
DK0869086T3 (da) Transportør
GR910100444A (en) Construction methods for reflecting objects
DE69415246D1 (de) Beleuchtungssystem
IS4115A (is) Ný peptíð
FI940109L (fi) Peptidejä
GB9404599D0 (en) Theatrical search lighting system
AP9400688A0 (en) Reflector studs for roads
DE69634464D1 (de) Cachespeicher
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
FR2737478B1 (fr) Citerne refrigeree
DE69634465D1 (de) Cachespeicher
IT1295973B1 (it) Procedimento per l'illuminazione di oggetti.
TR25655A (tr) Gizli
DE59601297D1 (de) Retroreflektor
KR950022086U (ko) 헬씨 영상반주장치
DE69406402D1 (de) Zwischenspeicher
SE9300323D0 (sv) System "anita"
UA1062S (uk) Штурмовий ніж-пістолет "баракуда"
BR1100812A (pt) Peptìdeo
SE9504467D0 (sv) Peptide
KR950014625U (ko) 자동차의 흡기장치

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TVW TELETHON INSTITUTE FOR CHILD HEALTH RESEARCH

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000101